Ipamorelin's receptor pharmacology and the preclinical basis of its research classification.
Ipamorelin is a synthetic pentapeptide developed as a growth-hormone secretagogue. Early pharmacology identified activity through a GHRP-like receptor system, now understood within ghrelin-receptor research.
What researchers examine
The foundational study compared growth-hormone release in rat pituitary cells and animal models and evaluated selectivity relative to other pituitary hormones. These experiments established a chemical-probe rationale, not a general human benefit.
How to interpret the evidence
Cell and animal endocrine readouts depend on species, anesthesia, sampling windows, baseline pulsatility, and assay design. A short peptide's activity also depends on sequence stereochemistry, terminal amidation, purity, and degradation. The cited work does not establish an approved clinical use for this research material.
Primary source
Research-use notice: For laboratory research use only. Not for human or veterinary use, ingestion, injection, therapeutic, diagnostic, or clinical use. This educational material summarizes research context; it is not medical advice and does not establish safety, efficacy, identity, purity, or suitability for any use.